Lineage Cell Therapeutics... (LCTX)
AMEX: LCTX
· Real-Time Price · USD
0.45
-0.02 (-4.26%)
At close: May 09, 2025, 3:59 PM
0.44
-2.98%
After-hours: May 09, 2025, 05:26 PM EDT
-4.26% (1D)
| Bid | 0.44 |
| Market Cap | 103.56M |
| Revenue (ttm) | 9.5M |
| Net Income (ttm) | -18.61M |
| EPS (ttm) | -0.09 |
| PE Ratio (ttm) | -5.04 |
| Forward PE | -7.27 |
| Analyst | Buy |
| Ask | 0.48 |
| Volume | 1,236,626 |
| Avg. Volume (20D) | 1,301,952 |
| Open | 0.46 |
| Previous Close | 0.47 |
| Day's Range | 0.43 - 0.47 |
| 52-Week Range | 0.37 - 1.25 |
| Beta | 1.42 |
About LCTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LCTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LCTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Lineage Cell Therapeutics Inc. is scheduled to release its earnings on May 13, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
5 months ago
-28.99%
Lineage Cell Therapeutics shares are trading lower...
Unlock content with
Pro Subscription
9 months ago
+1.8%
Lineage Cell Therapeutics shares are trading higher after the company reported better-than-expected Q2 financial results.
2 months ago · seekingalpha.com
Lineage Cell Therapeutics, Inc. (LCTX) Q4 2024 Earnings Call TranscriptLineage Cell Therapeutics, Inc. (NYSE:LCTX ) Q4 2024 Earnings Conference Call March 10, 2025 4:30 PM ET Company Participants Ioana Hone - Head of Investor Relations Brian Culley - Chief Executive Offi...
